HomeTrialNCT07502417
🔬NCT07502417Phase 1RECRUITING

A Phase 1 Study to Assess the Effect of ABBV-722 on Ethinyl Estradiol and Levonorgestrel Drug Levels in Healthy Adult Female Participants

Study Summary

The objective of this study is to assess the effect of repeated doses of ABBV-722 on the single dose pharmacokinetics (PK) of ethinyl estradiol and levonorgestrel.

View on ClinicalTrials.gov ↗
Study Details
Enrollment16 participants
Primary Completion
Lead SponsorAbbVie
Data Retrieved2026-04-11 02:51:51.324279+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.